These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30844536)

  • 21. Biased G Protein-Independent Signaling of Dopamine D
    Guitart X; Moreno E; Rea W; Sánchez-Soto M; Cai NS; Quiroz C; Kumar V; Bourque L; Cortés A; Canela EI; Bishop C; Newman AH; Casadó V; Ferré S
    Mol Neurobiol; 2019 Oct; 56(10):6756-6769. PubMed ID: 30919214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D
    Moritz AE; Free RB; Weiner WS; Akano EO; Gandhi D; Abramyan A; Keck TM; Ferrer M; Hu X; Southall N; Steiner J; Aubé J; Shi L; Frankowski KJ; Sibley DR
    J Med Chem; 2020 May; 63(10):5526-5567. PubMed ID: 32342685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo characterization of the agonist-dependent D3 dopamine receptor tolerance property.
    Cote SR; Kuzhikandathil EV
    Neuropharmacology; 2014 Apr; 79():359-67. PubMed ID: 24316466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils.
    Gabl M; Holdfeldt A; Sundqvist M; Lomei J; Dahlgren C; Forsman H
    Biochem Pharmacol; 2017 Dec; 145():114-122. PubMed ID: 28855087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-Functional Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward the Discovery of Biased Dopamine D1 Receptor Agonists.
    Li H; Mirabel R; Zimmerman J; Ghiviriga I; Phidd DK; Horenstein N; Urs NM
    ACS Chem Neurosci; 2022 Jun; 13(12):1818-1831. PubMed ID: 35658399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D
    Sánchez-Soto M; Boldizsar NM; Schardien KA; Madaras NS; Willette BKA; Inbody LR; Dasaro C; Moritz AE; Drube J; Haider RS; Free RB; Hoffman C; Sibley DR
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of radiolabeled antagonist assays for assessing agonism at D2 and D3 dopamine receptors: comparison with functional GTPγS assays.
    Zhen J; Antonio T; Ali S; Neve KA; Dutta AK; Reith ME
    J Neurosci Methods; 2015 Jun; 248():7-15. PubMed ID: 25840364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological targeting of G protein-coupled receptor heteromers.
    Moreno E; Casajuana-Martin N; Coyle M; Campos BC; Galaj E; Del Torrent CL; Seyedian A; Rea W; Cai NS; Bonifazi A; Florán B; Xi ZX; Guitart X; Casadó V; Newman AH; Bishop C; Pardo L; Ferré S
    Pharmacol Res; 2022 Nov; 185():106476. PubMed ID: 36182040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ARF6 and GASP-1 are post-endocytic sorting proteins selectively involved in the intracellular trafficking of dopamine D₂ receptors mediated by GRK and PKC in transfected cells.
    Cho DI; Zheng M; Min C; Kwon KJ; Shin CY; Choi HK; Kim KM
    Br J Pharmacol; 2013 Mar; 168(6):1355-74. PubMed ID: 23082996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist-induced endocytosis and receptor phosphorylation mediate resensitization of dopamine D(2) receptors.
    Cho D; Zheng M; Min C; Ma L; Kurose H; Park JH; Kim KM
    Mol Endocrinol; 2010 Mar; 24(3):574-86. PubMed ID: 20160122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of secretin receptor internalization differ from those of the beta(2)-adrenergic receptor.
    Walker JK; Premont RT; Barak LS; Caron MG; Shetzline MA
    J Biol Chem; 1999 Oct; 274(44):31515-23. PubMed ID: 10531354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation.
    Vaughan DJ; Millman EE; Godines V; Friedman J; Tran TM; Dai W; Knoll BJ; Clark RB; Moore RH
    J Biol Chem; 2006 Mar; 281(11):7684-92. PubMed ID: 16407241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine transporter is downregulated and its association with chaperone protein Hsc70 is enhanced by activation of dopamine D
    Chang PK; Chien KY; Chen JC
    Brain Res Bull; 2020 Dec; 165():263-271. PubMed ID: 33049353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2.
    Bono F; Tomasoni Z; Mutti V; Sbrini G; Kumar R; Longhena F; Fiorentini C; Missale C
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G protein-coupled receptor kinase-mediated phosphorylation regulates post-endocytic trafficking of the D2 dopamine receptor.
    Namkung Y; Dipace C; Javitch JA; Sibley DR
    J Biol Chem; 2009 May; 284(22):15038-51. PubMed ID: 19332542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. beta -Arrestins regulate protease-activated receptor-1 desensitization but not internalization or Down-regulation.
    Paing MM; Stutts AB; Kohout TA; Lefkowitz RJ; Trejo J
    J Biol Chem; 2002 Jan; 277(2):1292-300. PubMed ID: 11694535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple signaling routes involved in the regulation of adenylyl cyclase and extracellular regulated kinase by dopamine D(2) and D(3) receptors.
    Jin M; Min C; Zheng M; Cho DI; Cheong SJ; Kurose H; Kim KM
    Pharmacol Res; 2013 Jan; 67(1):31-41. PubMed ID: 23059541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of protein kinase C and actin-binding protein 280 in the regulation of intracellular trafficking of dopamine D3 receptor.
    Cho EY; Cho DI; Park JH; Kurose H; Caron MG; Kim KM
    Mol Endocrinol; 2007 Sep; 21(9):2242-54. PubMed ID: 17536008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arrestin-3 Agonism at Dopamine D
    Schamiloglu S; Lewis E; Keeshen CM; Hergarden AC; Bender KJ; Whistler JL
    Biol Psychiatry; 2023 Oct; 94(7):531-542. PubMed ID: 36931452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamin and beta-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization.
    Zhang J; Ferguson SS; Barak LS; Ménard L; Caron MG
    J Biol Chem; 1996 Aug; 271(31):18302-5. PubMed ID: 8702465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.